Twenty Beats of Ventricular Tachycardia is Non-Sustained VT (NSVT)
Twenty beats of ventricular tachycardia is classified as non-sustained ventricular tachycardia (NSVT), as it terminates spontaneously in less than 30 seconds. 1, 2
Definition and Classification
The standard definition of NSVT is clear and consistent across major guidelines:
- NSVT is defined as ≥3 consecutive ventricular beats at a rate >100 bpm (or ≥120 bpm in most studies) that terminates spontaneously in <30 seconds 1, 2, 3
- Sustained VT, in contrast, lasts longer than 30 seconds or requires termination due to hemodynamic compromise in less than 30 seconds 2
Twenty beats of VT, even at rapid rates, will almost always terminate in well under 30 seconds, placing it firmly in the NSVT category. 1
Clinical Significance in Risk Stratification
The distinction between sustained and non-sustained VT has critical prognostic implications:
In Hypertrophic Cardiomyopathy
- NSVT defined as ≥3 beats at ≥120 bpm is a major risk factor for sudden cardiac death 4, 5
- Greater weight should be placed on NSVT when runs are frequent (≥3 episodes), longer (≥10 beats), or faster (≥200 bpm) 4
- Twenty beats would be considered a "longer" run and should be taken seriously in risk assessment 4
In Ischemic Heart Disease
- In patients with prior MI and reduced LVEF (<40%), NSVT has adverse prognostic significance and warrants electrophysiologic testing for ICD consideration 6, 7
- However, prophylactic antiarrhythmic drugs for NSVT do NOT reduce mortality and should not be used 1
In Structurally Normal Hearts
- NSVT in the absence of structural heart disease generally carries a benign prognosis 8, 6
- The key is establishing whether structural or inherited heart disease is present 8
Common Pitfalls to Avoid
- Do not confuse the number of beats with duration in seconds - twenty beats at 150 bpm lasts only 8 seconds, well under the 30-second threshold 1, 2
- Do not treat asymptomatic NSVT with antiarrhythmic drugs - there is no mortality benefit and potential harm, particularly with Class IC agents in post-MI patients 1
- Do not dismiss NSVT in patients with structural heart disease - even brief episodes indicate increased sudden death risk and require comprehensive evaluation 2, 7
- Do not rely on 24-48 hour monitoring alone in hypertrophic cardiomyopathy - only 44.8% of NSVT episodes are captured within the first 48 hours, and prolonged monitoring may be superior 3